MAIL 164

In this final issue of MAIL:

› Paediatric regulation: requirements on marketing authorisation (MA) holders to submit paediatric information
› Update on Risk Management Plans (RMPs)
› Decentralised procedure MA applications with UK as Reference Member State (RMS)
› Variations to National (UK only) product licences
› Requests for MHRA to act as Reference Member State(RMS)
› Medicines and Healthcare products Regulatory Agency (MHRA) regulatory fees: proposals for 1 April 2008
› Important information regarding the submission of Centralised Procedure applications
› And finally - a brief history of MAIL

This is the final issue of MAIL. Information previously published in MAIL will now be available in our new ‘Medicines regulatory news’ section on the MHRA website at:

› http://www.mhra.gov.uk/mhra/medicinesregulatorynews

A free e-mail notification service is available which will alert subscribers when new content is available. To subscribe to this  service, please visit the ‘E-mail alerting service’ section on the MHRA website at http://www.mhra.gov.uk/mhra/emailalerts and select the content channel, ‘Medicines regulatory news’ (under the ‘Regulatory information – medicines’ section).